Back to comparisons

Comparison

Rhodiola Rosea vs Astragalus

FieldRhodiola RoseaAstragalus
Categoryadaptogenadaptogen
Dose range200–400mg500–3000mg
Half-life4h
Onset
EvidenceEVIDENCEAEVIDENCEB
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs4602800

The comparison in plain English

Auto-generated from data

Rhodiola Rosea and Astragalus are both in the adaptogen category respectively. Rhodiola Rosea An Arctic adaptogen used for centuries in Siberian, Scandinavian, and Tibetan traditional medicine. Astragalus Chinese TCM root used for immune support, longevity, and telomerase activation.

Bottom line

Rhodiola Rosea (evidence A, safety 5/5) has a weaker evidence base than Astragalus (evidence B, safety 5/5). Rhodiola Rosea has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Rhodiola Rosea if

Rhodiola Rosea is the better fit when your goal aligns with its mechanism (Rosavins and salidroside (the two standardised active compounds) modulate the HPA axis cortisol response under acute stress) and the dose range (200–400mg) suits your protocol. Half-life is 4h.

Choose Astragalus if

Astragalus is the better fit when your goal aligns with its mechanism (Polysaccharides activate innate immunity through TLR-4 and other receptors) and the dose range (500–3000mg) suits your protocol. Half-life is —h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →